Ameriprise’s OnKure Therapeutics OKUR Stock Holding History

Ameriprise’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,982	Closed	-$84.7K	–	4173
2024 Q3	$84.7K	Buy	+4,982	New	+$73.7K	﹤0.01%	3848

Other funds holding OKUR

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ameriprise's OKUR Position: Q4 2024 in Review

Ameriprise sold out of OnKure Therapeutics (OKUR) in Q4 2024, closing a stake of 4,982 shares — an estimated $84.7K sold.

Ameriprise first reported a position in OKUR in Q3 2024 and held it in 1 quarter. The position peaked at $84.7K in Q3 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q4 2024.

Ameriprise reported no remaining OnKure Therapeutics position as of Q4 2024 after selling out during the quarter.
Ameriprise sold 4,982 OnKure Therapeutics shares in Q4 2024, an estimated $84.7K.
Ameriprise first reported a position in OnKure Therapeutics in Q3 2024 and held it in 1 quarter.
Ameriprise's OnKure Therapeutics position peaked at $84.7K in Q3 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.